Oral anticoagulation and self-management: analysis of the factors that determine the feasibility of using self-testing and self-management in primary care

BMC Cardiovascular Disorders

Arrate Galo-Anza²  Isabel Lopez-Fernandez¹  Alejandro Garcia-Carro⁵  Aitziber Ostiza-Irigoyen³  Edurne Uranga Saez del Burgo⁴  Itziar Vergara-Mitxeltorena⁶  Eduardo Tamayo Aguirre² 

[1] Lasarte Health Centre, Gipuzkoa, Spain;Gros Health Centre, Donostia, Gipuzkoa, Spain;Usurbil Health Centre, Gipuzkoa, Spain;Pasai Donibane Health Centre, Gipuzkoa, Spain;Egia Health Centre, Donostia, Spain;Red de investigación en servicios de salud en enfermedades crónicas (REDISSEC), Centro de investigación en cronicidad Kronikgune, Osakidetza, Spain

关键词: Determinants;    Self-management;    Oral anticoagulants;   

Others  :  857549
DOI  :  10.1186/1471-2261-13-59

 received in 2013-06-28, accepted in 2013-08-19,  发布年份 2013

【 摘 要 】

Background

The skills of patients on oral anticoagulants are critical for achieving good outcomes with this treatment. Self-management, or the capacity of patients to control their INR level and adjust their treatment, is an effective strategy of treatment. Capacity of patients to self manage is determined by a range of factors. The identification of these factors would improve the design of self management programmes and in turn increase the number of patients able to self-manage. The objective of our study is to identify those factors that determine the ability of patients on oral anticoagulant therapy to achieve self-management of their treatment.

Design

This will be a three year quasi- experimental prospective study with a control group. 333 patients on anticoagulant therapy from five health centres of the Basque Health Service are to be followed up for a period of six months each after the intervention, to assess their ability to self-test and self-manage. The intervention will consist of a patient training programme involving the provision of information and practical training concerning their condition and its treatment, as well as how to use a portable blood coagulation monitoring device and adjust their anticoagulant dose.

Discussion

The ease-of-use of this technique lead us to believe that self-management is feasible and will represent an innovative advance that should have a substantial impact on the quality of life of this patients and their families as well as on the health care provision systems.

Trial registration

Osakidetza Protocol Record ISCIII-11/02285, Oral anticoagulation and self-management, ClinicalTrials.gov Identifier: NCT01878539

【 授权许可】

   
2013 Tamayo Aguirre et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Mashal A, Katz A, Shvartzman P: Atrial fibrillation: a primary care cross-sectional study. Isr Med Assoc J 2011, 13:666-671.
• [2]Jack A, Alan J, Jonathan L, Heinz V, Michael Hasenkam J: Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. Int J Cardiol 2005, 99(1):37-45. 15721497
• [3]Heneghan C, Alonso Coello MD, Garcia Alamino JM, Perera R, Meats E, Glasziou P: Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 367(9508):404-411.
• [4]Ansell JE: Empowering patients to monitor and manage oral anticoagulation therapy. JAMA 1999, 281:182-183.
• [5]Menendez-Jandula B, Souto JC, Oliver A, Montserrat I, Quintana M, Gich I, Bonfill X, Fontcuberta J: Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Ann Intern Med 2005, 142:1-10.
• [6]Cromheecke ME, Levi M, Colly LP, de Mol BJ, Prins MH, Hutten BA, Mak R, Keyzers KC, Buller HR: Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000, 356:97-102.
• [7]Ansell JE, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM, Fish L: Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995, 155:2185-2189.
• [8]Sawicki PT, For the Working Group for the Study of Patient Self-Management of Oral Anticoagulation: A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. JAMA 1999, 281(2):145-150.
• [9]Garcia-Alamino JM, Ward AM, Alonso-Coello P, Perera R, Bankhead C, Fitzmaurice D, Heneghan CJ: Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev 2010, CD003839.
• [10]Fitzmaurice DA, Murray ET, McCahon D, Holder R, Raftery JP, Hussain S, Sandhar H, Hobbs FD: Self management of oral anticoagulation: randomised trial. BMJ 2005, 331:1057.
• [11]Christensen TD, Johnsen SP, Hjortdal VE, Hasenkam JM: Self-management of oral anticoagulant therapy: a systematic review and meta-analysis. Int J Cardiol 2007, 118:54-61.